|
Match
|
Document |
Document Title |
|
|
6831073 |
Hormonal composition consisting of an oestrogen compound and of a progestational compound
A method of treating estrogenic deficiencies in women while further avoiding the appearance of osteoporosis, withdrawal bleeding and cardiovascular diseases in post-menopausal women without any...
|
|
|
6797282 |
Combination progestin oral contraceptive regimen
An oral contraception regimen which comprises sequentially administering two or more progestational agents exhibiting different effects on the human endometrium in combination with an estrogen. The...
|
|
|
6790463 |
Uses of targeted oxidative therapeutic formulation in arteriosclerosis
The use of a pharmaceutical formulation in treating coronary arteriosclerosis and a two-component pharmaceutical formulation. The pharmaceutical formulation contains peroxidic species or reaction...
|
|
|
6780855 |
11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS
This invention describes the new 11β-halogen-7α-substituted estratrienes of general formula I in which R 11 is a fluorine or chlorine atom, and the other substituents have the meanings that...
|
|
|
6759408 |
Combination regimens using progesterone receptor modulators
This invention relates to cyclic combination therapies and regimens utilizing substituted indoline derivative compounds which are antagonists of the progesterone receptor having the general...
|
|
|
6759399 |
Use of antimineralocorticoid compounds against narcotic withdrawal syndrome
The method of treating narcotic withdrawal symptoms in warm-blooded animals comprising administering to warm-blooded animals in need thereof an amount of a compound having anti-mineralocorticoid...
|
|
|
6716437 |
Topical composition and method for enhancing lipid barrier synthesis
The present invention relates to topical compositions useful in enhancing lipid synthesis in skin comprising an effective amount of cafestol or kahweol, or derivative thereof, in combination with a...
|
|
|
6696432 |
Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men
The present invention concerns the combination of dehydroepiandrosterone (DHEA) and at least one aromatase inhibitor and the use of such a combination to produce a medicament for treating relative...
|
|
|
6677324 |
Combination preparation of estrogen and anti-estrogen
The invention describes a combination preparation of an oestrogen and an antioestrogen, characterized in that the oestrogen is selected from the group consisting of 17-β-oestradiol,...
|
|
|
6677327 |
Phytosterol and phytostanol compositions
The present invention relates to an edible phytosterol or phytostanol composition useful in the food industry and to methods of preparing such an edible composition. The edible composition...
|
|
|
6656929 |
Pharmaceutical composition with a synthetic natural progesterone and oestradiol base and its preparation process
The object of this invention is a pharmaceutical composition with a synthetic natural progesterone and oestradiol base coming in the form of a tablet, characterised by the fact that it has a...
|
|
|
6642219 |
Progestogen-antiprogestogen regimens
An estrogen-free contraceptive is provided which does not have the bleeding-related drawbacks of conventional progestogen-only pills. Thus the invention is a contraceptive kit comprising a combined...
|
|
|
6638547 |
Prepared foods containing triglyceride-recrystallized non-esterified phytosterols
A prepared food product for ingestion by mammals is described and methods for preparing such products. The food product includes an oxidation-resistant fat-based composition substantially free of...
|
|
|
RE38253 |
Composition for contraception
A combination product for oral contraception is disclosed comprising an estrogen selected from 2.0 to 6.0 mg of 17β-estradiol and 0.020 mg of ethinylestradiol; and a gestagen selected from 0.25...
|
|
|
6617319 |
Methods of use for 2-deoxy ecdysterone
The invention provides a process for the isolation of 2-deoxy ecdysterone from Zoanthus sp process comprising the steps (a) preparing crude methanol extract of Zoanthus sp., (b) subjecting the...
|
|
|
6583129 |
Administration of non-oral androgenic steroids to women
The present invention provides compositions, methods, and kits for improving health in a woman having elevated SHBG levels, or who is receiving oral estrogen supplementation, by non-orally...
|
|
|
6572893 |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
Methods for preparing dry powders having hydrophobic and hydrophilic components comprise combining solutions of the components and spray drying them simultaneously in a spray dryer. The hydrophilic...
|
|
|
6566353 |
Method of treating malignancy associated hypercalcemia using active vitamin D analogues
Methods utilizing active vitamin D analogs for the treatment of malignancy-associated hypercalcemia. Methods comprise the application of an effective amount of a hypocalcemic vitamin D compound to...
|
|
|
6559139 |
Combination chemotherapy
This invention relates to combination chemotherapy, particularly involving vitamin D or a derivative thereof. In one aspect, the invention provides a method of killing a cell by first administering...
|
|
|
6552010 |
Treatment of SLE with dehydroepiandrosterone
This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.
|
|
|
6531463 |
Method for producing a fat mixture
A method for producing a fatty blend of β-sitosterol, or of β-sitosterol and β-sitostanol, which is useful for lowering the serum total cholesterol and LDL-cholesterol levels which method...
|
|
|
6511969 |
Method for reducing coronary artery reactivity
A method for reducing coronary artery reactivity. A predetermined amount of natural progesterone is provided by a convenient and pleasant delivery system to the blood stream, sufficient to reduce...
|
|
|
6506390 |
Progestogen-anti-progestogen regimens
A contraceptive and/or HRT (hormone replacement therapy) kit comprising sequential daily dosage units each containing as the sole contraceptively effective ingredient a progestogen, or as the...
|
|
|
6503939 |
Combination regimens using 3,3-substituted indoline derivatives
This invention relates to cyclic combination therapies and regimens utilizing substituted indoline derivative compounds that are antagonists of the progesterone receptor having the structure: ...
|
|
|
6500814 |
Hormonal contraceptive
The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a process for the combined, continuous administration of the...
|
|
|
6498154 |
Cyclic regimens using quinazolinone and benzoxazine derivatives
This invention relates to cyclic combination therapies utilizing, in combination with progestins, estrogens, or both, compounds which are progesterone receptor antagonists of the general structure:...
|
|
|
6491952 |
Cholesterol lowering composition
The present invention concerns a composition containing a cholesterol lowering component such as β-sitosterol and/or β-sitostanol in a monomolecular, low associated or “cluster” form, where a...
|
|
|
6479475 |
Oral contraceptive
This invention provides a method of contraception which comprises administering to a female of child bearing age for 23-25 consecutive days, a first phase combination of a progestin at a daily...
|
|
|
6465446 |
Treatment of dermatitis by the topical application of &Dgr 5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof
Dermatitis can be treated by the administration of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof, such as Δ5-androstene-3β-acetoxy-7,17 dione, to the skin.
|
|
|
6451777 |
Method for regulating hair growth
A method for regulating the growth and loss of hair via the use of compositions containing a compound selected from the group consisting of lupane triterpenes, derivatives of lupane triterpenes,...
|
|
|
6444659 |
Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesterolemic agents
A hypocholesterolemic composition containing: (a) an active ingredient selected from the group consisting of a phytostenol, a phytostenol ester, and mixtures thereof; and (b) a potentiating agent...
|
|
|
6423698 |
Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia
A combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia in susceptible warm-blooded animals which comprises administering a combination of two or more compounds...
|
|
|
6399138 |
Sterol concentrates its application and preparation
The invention concerns concentrates of shea sterols in glycerides with more than 12.5 wt % shea sterols, the preparation thereof by enzymic hydrolysis of glycerides in shea oils or fractions...
|
|
|
6391370 |
Micromilling plant sterols and emulsifiers
Plant sterols have been shown to be cholesterol-reducing agents in human serum. In the present invention, plant sterols, plant stanols, plant sterol esters and other non-toxic sterols are...
|
|
|
6376477 |
Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism
The inhibition of natural bone formation experienced in the prophylaxis and/or treatment of bone resorption disease with a bisphosphonic acid or a pharmaceutically acceptable salt thereof is...
|
|
|
6362237 |
Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
This invention describes the use of at least one compound with a progesterone-antagonistic (PA) action and at least one compound with an antiestrogenic (AE) action, each in a...
|
|
|
6352980 |
Estrenes for inducting hypothalamic effects
The invention relates to estrene steroids, which bind to neuroepithelial receptors. The steroid is preferably administered in the form of a pharmaceutical composition containing one or more...
|
|
|
6333057 |
Composition and method for topical treatment of androgenic alopecia
This invention relates to the topical and oral treatment of hair loss, especially androgenic alopecia, by providing formulations that include anti-androgens, especially extracts of the saw palmetto...
|
|
|
6329354 |
Methods for the treatment of osteoporosis
Methods of treatment for osteoporosis in a human or other animal subject, comprising: administering a bone-active phosphonate to said subject, at a level of at least about 0.1 LED per day of said...
|
|
|
6323191 |
Small molecule chloride transport
Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride (Cl - ) channel regulated by phosphorylation and intracellular nucleotides. CFTR is the major Cl - transport pathway in...
|
|
|
6312722 |
Pharmaceutical combined preparation, kit and method for hormonal contraception
The present invention describes a two-stage pharmaceutical combined preparation for hormonal contraception containing at least 30 daily unit doses, which preparation, in its first stage, comprises...
|
|
|
6277829 |
Process for preparing of aqueous formulation for opthalmic use
The present invention describes a process for the preparation of aqueous formulations containing azithromycin for ophthalmic use, as well any formulations obtained by this process and their topical...
|
|
|
6277431 |
Anticholesterolemic edible oil
An edible oil is provided that decreases the synthesis, absorption and blood level of cholesterol by a human patient, increases the excretion of cholesterol from the human patient, curtails...
|
|
|
6268377 |
Method for treating androgen-related conditions
The present invention provides for the combined use of 5α-reductase inhibitors together with calcium channel blockers for the treatment of benign prostatic hyperplasia (BPH), prostate cancer,...
|
|
|
6230713 |
Determining a treatment plan for patients undergoing thrombotic event by monitoring P-selectin
A treatment plan for patients suffering from a thrombotic event can be determined by measuring membrane bound and/or soluble P-selectin. The degree of reperfusion can be determined by assessing the...
|
|
|
6228852 |
Transdermal application of naturally occurring steroid hormones
The invention features a physiologically acceptable cream that contains estrogen, progesterone, and testosterone molecules that are identical to the estrogen, progesterone, and testosterone...
|
|
|
6225297 |
Combination contraceptive
This invention relates to a combination product that consists of individual dosage units of a competitive progesterone antagonist and, in addition, sequentially provided individual dosage units of...
|
|
|
6225299 |
Hormonal agent for skin treatment
The pharmaceutical composition, especially for treating skin with seborrhea, Acne vulgaris and androgonically conditioned alopecia, contains a hormonal agent including the gestogen, dienogest, or a...
|
|
|
6225298 |
Compositions and methods for contraception and for treatment of benign gynecological disorders
Compositions and methods for use in preventing conception or treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent [e.g., progesterone (progestin,...
|
|
|
6214815 |
Triphasic oral contraceptive
A method of contraception in which an estrogen and a progestogen are administered daily in a three phase sequence for 21 days is disclosed. In the first phase a combination of an estrogen and a...
|